PVAI enables leading life sciences companies to transform pharmacovigilance and patient safety through AI. PVAI was incubated inside of Genpact to build out a modular, validated suite of industry-leading Artificial Intelligence SaaS modules developed specifically to solve the myriad challenges in Pharmacovigilance (PV). PVAI products and solutions enable life sciences companies to bring the power of cutting edge AI seamlessly into safety operations across the globe. As of February 1, 2023 PVAI is now an independent company continuing its mission to become the industry standard for intelligence and automation in Pharmacovigilance.
